Pediatric cardiology · 2026
Prenatally vs. Postnatally Diagnosed Congenitally Corrected Transposition of the Great Arteries is Associated with Higher Rates of Conduction Disease, Intervention and Earlier Mortality.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Nield Lynne E, Grasswill Mélanie, Romefort Bénédicte, Prigent Solène, Belli Emre, Babu-Narayan Sonya V, Elder Robert W, Ladouceur Magalie, Khairy Paul, Kowalik Ewa, Kalfa David M, Conway Miriam, Werner Oscar, Sellal Jean-Marc, Monier Astrid, Buratto Edward, Padovani Paul, Barron David J, Bacha Emile A, Gatzoulis Michael A, McLeod Christopher J, Karakachoff Matilde, Baruteau Alban-Elouen, DISCO study group
Аннотация
Congenitally corrected transposition of the great arteries (ccTGA) with biventricular physiology is presumed to carry a favorable outcome. We aimed to explore the differences in associated diagnoses (including conduction disease), management and outcomes among prenatally vs. postnatally diagnosed ccTGA cases. Secondary objective was to examine outcomes in isolated ccTGA. An international, multicenter, retrospective cohort study was conducted in 29 tertiary hospitals (6 countries) from 1990 to 2018. Patients with a single ventricle, heterotaxy syndrome, or valvar atresia were excluded. Of 331 ccTGA patients with a median follow-up of 8.6 years [IQR: 3.5–14.1], 128 (38.7%) were diagnosed prenatally at a median gestational age of 22 weeks. As compared to the postnatal group, prenatally diagnosed patients experienced earlier cardiac conduction disorders (median age at diagnosis of conduction disorders: 0.3 versus 2.7 years, p = 0.010), earlier pacemaker implantation (median age at pacing: 6.5 years [2.5–11.6] versus 0.9 year [0.1-3.0], p < 0.001) and earlier surgical intervention (intervention-free survival rate at 3 years: 50.3% versus 34.7%, p < 0.001). The 3-year survival rate was significantly lower in patients diagnosed prenatally (91.1% versus 98.4%, p = 0.002) and the median age at death was significantly younger among patients diagnosed prenatally (0.2 versus 7.0 years, p < 0.001). In both groups, isolated ccTGA (n = 63, 19%) was associated with superior outcomes with no intervention in 46.8% and only one death. Prenatally diagnosed patients with ccTGA had earlier conduction disorders and interventions than postnatally diagnosed patients and died at a younger age. Outcomes were best in patients with isolated ccTGA.